Market Slips After Rising Briefly, Dendreon Still Soaring

Despite the GDP growth we’ve experienced here in the US, downgrades on Greek banks by Moody’s soured the mood quickly. After a brief spurt upward, the Dow fell and is currently down 45 points at 11,121.

Goldman Sachs (GS) is down 7.3% to $148 and Dendreon (DNDN)  – chart below -is still climbing after yesterday’s FDA-approval, currently up 8.5% to $54.48.

DNDN Chart Apr 30th

Photo: Google Finance

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.